Exenatide improves antioxidant capacity and reduces the expression of LDL receptors and PCSK9 in human insulin-secreting 1.1E7 cell line subjected to hyperglycemia and oxidative stress
Łukasz Bułdak
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Profil OrcidWyszukaj tego autora
, Estera Skudrzyk
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Profil OrcidWyszukaj tego autora
, Grzegorz Machnik
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Profil OrcidWyszukaj tego autora
, Aleksandra Bołdys
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Profil OrcidWyszukaj tego autora
, Rafał Jakub Bułdak
Institute of Medical Sciences, University of OpoleOpole, Poland
Profil OrcidWyszukaj tego autora
oraz Bogusław Okopień
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Profil OrcidWyszukaj tego autora
20 lut 2022
O artykule